Transgenic Animal Market
Description
The Global Transgenic Animal Market is estimated to be valued at USD 3.96 Bn in 2025 and is expected to reach USD 7.92 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032. The global transgenic animal market represents a revolutionary segment within biotechnology and pharmaceutical industries, encompassing genetically modified animals engineered for scientific research, drug development, and therapeutic applications. Transgenic animals, created through genetic engineering techniques, carry foreign genes or modified endogenous genes that enable researchers to study human diseases, test potential treatments, and develop novel therapeutic approaches. These animals serve as crucial living models for understanding complex biological processes, genetic disorders, and disease mechanisms that would be impossible to replicate in traditional laboratory settings.
The market primarily includes transgenic mice, rats, rabbits, pigs, and other laboratory animals specifically designed for biomedical research, pharmaceutical testing, and academic studies. With increasing demand for personalized medicine, growing prevalence of genetic disorders, and rising investments in biotechnology research, the transgenic animal market has experienced significant growth. The industry plays a pivotal role in accelerating drug discovery processes, reducing time-to-market for new therapeutics, and enhancing the success rates of clinical trials through more accurate pre-clinical testing models.
Market Dynamics
The global transgenic animal market is driven by several compelling factors that continue to propel its expansion across pharmaceutical and biotechnology sectors. Primary growth drivers include the escalating demand for personalized medicine and targeted therapies, which require sophisticated animal models to understand individual genetic variations and treatment responses. The increasing prevalence of genetic disorders, cancer, diabetes, and neurological diseases has intensified the need for accurate disease models that transgenic animals uniquely provide. Rising investments in biotechnology research and development, coupled with government funding for genomic studies, have created a robust foundation for market growth.
The growing adoption of transgenic animals in drug discovery and development processes significantly reduces the time and cost associated with bringing new medications to market, making them indispensable tools for pharmaceutical companies. However, the market faces notable restraints including stringent regulatory frameworks governing animal research, ethical concerns surrounding genetic modification of animals, and high costs associated with developing and maintaining transgenic animal colonies. Complex breeding procedures, specialized housing requirements, and skilled personnel needs contribute to operational challenges.
Additionally, the emergence of alternative testing methods such as organ-on-chip technologies and computer modeling presents potential competitive threats. Despite these challenges, substantial opportunities exist in emerging markets where biotechnology research is expanding rapidly, increasing applications in agriculture for developing disease-resistant livestock, and growing demand for transgenic animals in emerging therapeutic areas including gene therapy and regenerative medicine research.
Key Features of the Study
The market primarily includes transgenic mice, rats, rabbits, pigs, and other laboratory animals specifically designed for biomedical research, pharmaceutical testing, and academic studies. With increasing demand for personalized medicine, growing prevalence of genetic disorders, and rising investments in biotechnology research, the transgenic animal market has experienced significant growth. The industry plays a pivotal role in accelerating drug discovery processes, reducing time-to-market for new therapeutics, and enhancing the success rates of clinical trials through more accurate pre-clinical testing models.
Market Dynamics
The global transgenic animal market is driven by several compelling factors that continue to propel its expansion across pharmaceutical and biotechnology sectors. Primary growth drivers include the escalating demand for personalized medicine and targeted therapies, which require sophisticated animal models to understand individual genetic variations and treatment responses. The increasing prevalence of genetic disorders, cancer, diabetes, and neurological diseases has intensified the need for accurate disease models that transgenic animals uniquely provide. Rising investments in biotechnology research and development, coupled with government funding for genomic studies, have created a robust foundation for market growth.
The growing adoption of transgenic animals in drug discovery and development processes significantly reduces the time and cost associated with bringing new medications to market, making them indispensable tools for pharmaceutical companies. However, the market faces notable restraints including stringent regulatory frameworks governing animal research, ethical concerns surrounding genetic modification of animals, and high costs associated with developing and maintaining transgenic animal colonies. Complex breeding procedures, specialized housing requirements, and skilled personnel needs contribute to operational challenges.
Additionally, the emergence of alternative testing methods such as organ-on-chip technologies and computer modeling presents potential competitive threats. Despite these challenges, substantial opportunities exist in emerging markets where biotechnology research is expanding rapidly, increasing applications in agriculture for developing disease-resistant livestock, and growing demand for transgenic animals in emerging therapeutic areas including gene therapy and regenerative medicine research.
Key Features of the Study
- This report provides in-depth analysis of the global transgenic animal market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global transgenic animal market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Charles River Laboratories, Taconic Biosciences, genOway, Cyagen Biosciences, Biocytogen, Transgenic Inc, Ozgene, PolyGene, Hera BioLabs, Ingenious Targeting Laboratory, Applied StemCell, GemPharmatech, Harbour BioMed, Crown Bioscience, and Pharmaron
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global transgenic animal market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transgenic animal market
- Animal Type Insights (Revenue, USD Bn, 2020 - 2032)
- Mice
- Rats
- Zebrafish
- Pigs
- Cattle
- Sheep
- Goats
- Chickens
- Others (Non-human primates rabbits)
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Microinjection
- Embryonic Stem Cell (ESC) Injection
- Nuclear Transfer (Cloning)
- CRISPR/Cas9 and Other Gene Editing Technologies
- Viral Vector-mediated Transgenesis
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Biomedical Research
- Drug Discovery and Development
- Toxicology and Safety Testing
- Disease Modeling
- Regenerative Medicine
- Xenotransplantation
- Biopharmaceutical Production
- Agricultural Trait Enhancement
- Disease Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurological Disorders
- Cardiovascular Diseases
- Metabolic Disorders
- Immunological and Autoimmune Diseases
- Genetic and Rare Diseases
- Infectious Diseases
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Agricultural Research Organizations
- Government and Regulatory Laboratories
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- Taconic Biosciences
- genOway
- Cyagen Biosciences
- Biocytogen
- Transgenic Inc
- Ozgene
- PolyGene
- Hera BioLabs
- Ingenious Targeting Laboratory
- Applied StemCell
- GemPharmatech
- Harbour BioMed
- Crown Bioscience
- Pharmaron
Table of Contents
168 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Transgenic Animal Market, By Animal Type
- Global Transgenic Animal Market, By Technology
- Global Transgenic Animal Market, By Application
- Global Transgenic Animal Market, By Disease Area
- Global Transgenic Animal Market, By End User
- Global Transgenic Animal Market, By Region
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- 4. Global Transgenic Animal Market, By Animal Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Zebrafish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pigs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chickens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Non-human primates rabbits)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 5. Global Transgenic Animal Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microinjection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Embryonic Stem Cell (ESC) Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nuclear Transfer (Cloning)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CRISPR/Cas9 and Other Gene Editing Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral Vector-mediated Transgenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 6. Global Transgenic Animal Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biomedical Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Toxicology and Safety Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Disease Modeling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biopharmaceutical Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Agricultural Trait Enhancement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 7. Global Transgenic Animal Market, By Disease Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunological and Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic and Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 8. Global Transgenic Animal Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Agricultural Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government and Regulatory Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 9. Global Transgenic Animal Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
- 10. Competitive Landscape
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taconic Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- genOway
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyagen Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocytogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Transgenic Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ozgene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PolyGene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hera BioLabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ingenious Targeting Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Applied StemCell
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GemPharmatech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harbour BioMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pharmaron
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 12. References and Research Methodology
- References
- Research Methodology
- About us
- *Browse 32 market data tables and 28 figures on ‘Transgenic Animal Market' - Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
